BRAF and colorectal cancer: Even though tumors of all clinico-pathological subtypes were represented among the biomarker panel methylation positive samples, the very few negative colorectal cancers were generally of the MSS phenotype and were BRAF wild-type, compatible with CIMP negative tumors [34].